20290 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide Nitrofurans
FATTY ACID COMPOUNDS
#2METHODS FOR TREATING CANCER
#3METHODS COMPRISING DETECTION OF ADP-HEPTOSE
#4COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION
#5METHODS FOR IDENTIFYING ADAR1 INHIBITORS, AND COMPOSITIONS AND METHODS OF USE IN TREATING CANCER
#6METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE
#7APPLICATION OF HYDRAZIDE COMPOUND IN TUMOR TREATMENT
#8Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease
#9COMPOSITIONS AND METHODS FOR AMELIORATING HELICOBACTERACEAE INFECTIONS
#10BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#11Wound-care composition and method of use
#12L-SEPIAPTERIN AND METHODS OF USE FOR TREATING DISEASES AND DISORDERS
#13METHOD TO PREVENT AND TREAT MACULAR DEGENERATION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#14COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS
#15New use of R-enantiomer of adrenergic beta 2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations
#16Iron chelators in tumor therapy
#17ANTIBACTERIAL COMBINATIONS
#18METHOD TO PREVENT AND TREAT GINGIVAL RECESSION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#19Method to prevent and treat macular degeneration by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
#20Combination of a ubiquitin-conjugating enzyme complex inhibitor and antihypertensive and/or hypoglycemic drugs in diabetic kidney disease
#21POLYMER FILMS WITH ANTIMICROBIAL AGENTS
#22Antibacterial composition containing ADK protein as active ingredient, or composition for preventing or treating sepsis
#23Nitrofuran Derivatives That Induce Apoptosis in Breast Cancer Cells by Activating Protein Expression
#24AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES
#25Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides
#26Treatment for myopathy
#27Antifungal treatment
#28ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS
#29Combinations of Oral Medicaments Bonded by a Wrapping
#30Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
#31Methods, pharmaceutical compositions, therapeutic systems, and compounds for treating B cell malignancies
#32PRODRUGS FOR TREATING MICROBIAL INFECTIONS
#33Methods of treating giardiasis
#34Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
#35AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES
#36Nitrofuran compounds for the treatment of cancer and angiogenesis
#37Synergistic pharmaceutical composition for topical applications
#38Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#39DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERS
#40Antifungal Treatment
#41Nitrofuran compounds for the treatment of cancer and angiogenesis
#42Combination of Oral Medicaments Bonded by a Wrapping
#43Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#44Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#45METHODS FOR TREATING RESPIRATORY DISORDERS
#46Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders
#47ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS
#48Imidazole-Based Hmg-Coa Reductase Inhibitors
#49Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
#50Anti-glycation agents for preventing age- diabetes- and smoking-related complications
#51Composition for treating wounds, dermatitis, inflammation, and irritation